Πέμπτη 26 Δεκεμβρίου 2019

Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma

Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma: Publication date: March 2020Source: Biomedicine & Pharmacotherapy, Volume 123Author(s): Abdolreza Esmaeilzadeh, Safa Tahmasebi, Seyyed Shamsadin AthariAbstractDespite the current advancements, cancer treatment approaches have limitations restricting their cure rate. Immunotherapy techniques are among novel and promising cancer therapeutic approaches. Therapeutic antibodies and adoptive cell therapy (ACT) are the main branches of immunotherapy. T lymphocytes and genetically engineered cells are among important cells which can be used in ACT. This review has focused on recent advances in engineered cell-based immunotherapy based on T lymphocytes with chimeric antigen receptors (CARs). CARs are recombinant receptors expressing T cell signaling domains with or without co-stimulatory molecules....


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου